Editor's note channel feed

Who are the women blaz­ing trails in bio­phar­ma R&D? Nom­i­nate them for End­points' spe­cial re­port

7 years ago

Come join me dur­ing my round-the-world biotech ad­ven­ture in Oc­to­ber, with events in Lon­don and Shang­hai — plus

7 years ago

The 10 most pop­u­lar sto­ries in End­points News — so far in 2017

8 years ago

Let the joust­ing be­gin: Which top bio­phar­ma com­pa­nies are look­ing to make a splash at ASH?

8 years ago
R&D

We've tak­en a big step for­ward at End­points News — and with your help, we'll make more strides

8 years ago

The busi­ness mod­el of End­points News — and why you should sub­scribe

8 years ago

End­points In­sid­er: The world’s old­est new biotech pub ends its 12th month on a roll

9 years ago

Cheers! End­points News turns 1 to­day — and we're un­wrap­ping in­fo on a new sub­scrip­tion plan

9 years ago

The 10 most pop­u­lar re­ports in End­points News — so far

9 years ago

What is End­points?

10 years ago
First page Previous page 123
A service from the Financial Times